VRNA Verona Pharma plc: institutional ownership and insider trading
8 funds reported holding $29.9M of Verona Pharma plc in their latest 13F filings; in Q1 2026 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Largest institutional holders of VRNA
- Point72 Asia (Singapore) Pte. Ltd. — $8.54M
- Burren Capital Advisors Ltd — $6.74M
- Cubist Systematic Strategies, LLC — $5.70M
- Alerce Investment Management, L.P. — $4.09M
- WOLVERINE TRADING, LLC — $2.86M
- CAXTON ASSOCIATES LP — $1.37M
- Cahill Wealth Management, LLC — $512K
- First Horizon Advisors, Inc. — $108K
Recent VRNA insider trades
- Aug 1, 2025: Sinha Vikas sold 4,328 shares ($56.9K)
- Aug 1, 2025: Shah Mahendra sold 3,608 shares ($47.4K)
- Aug 1, 2025: Edwards Martin sold 10,808 shares ($142K)
- Aug 1, 2025: Ebsworth David R sold 1,904 shares ($25.0K)
5%+ owners
- BlackRock Portfolio Management LLC: 6.0% (Schedule 13G, filed Oct 17, 2025)